Alpha GPC: Difference between revisions
Jump to navigation
Jump to search
(added update re Rapid Alert System) |
No edit summary |
||
| Line 5: | Line 5: | ||
UPDATE: As of March 2025 an application for authorisation as a Novel food has been lodged with EFSA, when a decision is reached this page will be updated. | UPDATE: As of March 2025 an application for authorisation as a Novel food has been lodged with EFSA, when a decision is reached this page will be updated. | ||
UPDATE: | UPDATE: As of May 2026, it has passed the safety assessment by EFSA [Safety of L‐alpha‐glycerylphosphorylcholine (L‐alpha‐GPC) from soya phospholipids (lecithin) as a novel food pursuant to Regulation (EU) 2015/2283 - - 2026 - EFSA Journal - Wiley Online Library] | ||
[[Category:Ingredients]] | [[Category:Ingredients]] | ||
[[Category:Medicinal]] | [[Category:Medicinal]] | ||
Revision as of 14:58, 19 May 2026
L-alpha-glycerylphosphorylcholine.
Commonly requested in sport and nootropic products. This is likely medicinal according to the HFMA.
UPDATE: As of March 2025 an application for authorisation as a Novel food has been lodged with EFSA, when a decision is reached this page will be updated.
UPDATE: As of May 2026, it has passed the safety assessment by EFSA [Safety of L‐alpha‐glycerylphosphorylcholine (L‐alpha‐GPC) from soya phospholipids (lecithin) as a novel food pursuant to Regulation (EU) 2015/2283 - - 2026 - EFSA Journal - Wiley Online Library]